Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_295cf220ea0319018a64964f2a8d2b34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02c28920b0de63f2dc0fda7bc8fe8fcf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d25fcad3dfe2651713fb3dfaf4fca7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7b8d925a66b1b4453bb710dd4e22155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_df874e3cf88adba3792dc9d5b5776180 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8046369912ae730134d1762f23d0415 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-212 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-243 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
filingDate |
2009-11-27^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b804c61ef68988b739f3a46add563449 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bef291a0cf92fe4ebdff6238a2a983b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4b6b187492556d5b8732c81a919b3c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da84f727606361d1f745fcc193e549d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9735f1cb3156296d0e68fae172f3658 |
publicationDate |
2010-06-03^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2010060990-A1 |
titleOfInvention |
Use of p2x7 pathway for assessing the sensitivity of a subject to a cancer treatment |
abstract |
The present invention concerns methods for assessing the sensibility of a subject to an anticancer treatment, for screening compounds which are useful for treating a cancer and for determining the likelihood of a metastatic relapse in a subject. The methods are based on the finding that a non-functional P2X7-elicited NALP3 inflammasome pathway in a subject is indicative of a resistance to treatment. The invention further concerns methods for treating a cancer and for restoring the sensitivity of the subject to a cancer treatment. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9920123-B2 |
priorityDate |
2008-11-27^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |